StonvexLoading…
StonvexStonvexStonvexCore line items from EXPD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.78B | $11.07B | $8.21B | $5.32B |
Operating Income | $294.83M | $1.05B | $801.64M | $513.59M |
Net Income | $229.61M | $810.33M | $609.63M | $387.37M |
EPS (Diluted) | $1.71 | $5.95 | $4.46 | $2.82 |
Total Assets | $4.78B | $4.89B | $4.78B | $4.79B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.32B | $1.31B | $1.19B | $1.16B |
Free Cash Flow OCF − CapEx | $296.62M | $953.40M | $683.08M | $492.81M |
Shares Outstanding | 132.02M | 133.88M | 134.02M | 135.13M |